BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26421273)

  • 1. Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.
    Feng J; Shi W; Zhang S; Zhang Y
    Emerg Microbes Infect; 2015 Aug; 4(8):e51. PubMed ID: 26421273
    [No Abstract]   [Full Text] [Related]  

  • 2. Borrelia burgdorferi Microarray Analysis.
    Iyer R; Schwartz I
    Methods Mol Biol; 2018; 1690():115-126. PubMed ID: 29032541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lingering Lyme.
    Moyer MW
    Sci Am; 2015 Sep; 313(3):16-8. PubMed ID: 26455088
    [No Abstract]   [Full Text] [Related]  

  • 4. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi.
    Dolan MC; Zeidner NS; Gabitzsch E; Dietrich G; Borchert JN; Poché RM; Piesman J
    Am J Trop Med Hyg; 2008 May; 78(5):803-5. PubMed ID: 18458316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.
    Feng J; Li T; Yee R; Yuan Y; Bai C; Cai M; Shi W; Embers M; Brayton C; Saeki H; Gabrielson K; Zhang Y
    Discov Med; 2019 Mar; 27(148):125-138. PubMed ID: 30946803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice, after antibiotic treatment.
    Liegner KB
    J Infect Dis; 2003 May; 187(10):1676; author reply 1676. PubMed ID: 12721952
    [No Abstract]   [Full Text] [Related]  

  • 7. Borrelia burgdorferi Transcriptome Analysis by RNA-Sequencing.
    Lybecker M; Henderson KC
    Methods Mol Biol; 2018; 1690():127-136. PubMed ID: 29032542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
    Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
    Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme disease: scratching the surface.
    Phillips SE; Harris NS; Horowitz R; Johnson L; Stricker RB
    Lancet; 2005 Nov; 366(9499):1771. PubMed ID: 16298211
    [No Abstract]   [Full Text] [Related]  

  • 10. Borrelia burgdorferi--traveling incognito?
    Fikrig E; Narasimhan S
    Microbes Infect; 2006 Apr; 8(5):1390-9. PubMed ID: 16698304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.
    Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J
    PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.
    Mosel MR; Carolan HE; Rebman AW; Castro S; Massire C; Ecker DJ; Soloski MJ; Aucott JN; Eshoo MW
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036693
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
    Feng J; Auwaerter PG; Zhang Y
    PLoS One; 2015; 10(3):e0117207. PubMed ID: 25806811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostics and treatment of Lyme borreliosis].
    Oksi J
    Duodecim; 2000; 116(6):605-12. PubMed ID: 11787113
    [No Abstract]   [Full Text] [Related]  

  • 15. Borrelia burgdorferi, the Lyme disease spirochete, possesses genetically-encoded responses to doxycycline, but not to amoxicillin.
    Saylor TC; Casselli T; Lethbridge KG; Moore JP; Owens KM; Brissette CA; Zückert WR; Stevenson B
    PLoS One; 2022; 17(9):e0274125. PubMed ID: 36178885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
    Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
    J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
    [No Abstract]   [Full Text] [Related]  

  • 17. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.
    Baranton G; Postic D; Saint Girons I; Boerlin P; Piffaretti JC; Assous M; Grimont PA
    Int J Syst Bacteriol; 1992 Jul; 42(3):378-83. PubMed ID: 1380285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Lyme disease.
    Med Lett Drugs Ther; 2016 May; 58(1494):57-8. PubMed ID: 27148921
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular characterization of Borrelia burgdorferi from case of autochthonous Lyme arthritis.
    Brummitt SI; Barbour AG; Hue F; Kjemtrup AM
    Emerg Infect Dis; 2014 Dec; 20(12):2168-70. PubMed ID: 25423131
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha.
    Stricker RB; Johnson L
    J Infect Dis; 2008 May; 197(9):1352-3. PubMed ID: 18422450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.